Vivos Therapeutics (VVOS) EBIT Growth (1y) (2021 - 2026)
Powered by 
Analysis
Vivos Therapeutics (VVOS) EBIT Growth (1y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Align Technology | 11.30 Bn | 10.20 Bn | 757.43 Mn | -5.53% |
| 2 | Envista Holdings | 4.38 Bn | 3.26 Bn | 407.00 Mn | 73.43% |
| 3 | Dentsply Sirona | 2.27 Bn | 2.03 Bn | 493.00 Mn | 164.06% |
| 4 | Milestone Scientific | 37.81 Mn | 35.20 Mn | 1.56 Mn | 58.55% |
| 5 | Dror Ortho-Design | 9.77 Mn | 9.68 Mn | - | 32.23% |
| 6 | Vivos Therapeutics | 2.76 Mn | 790,007.20 | 2.95 Mn | 0.82% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.82% |
| Mar 31, 2026 | -68.84% |
| Dec 31, 2025 | -127.44% |
| Sep 30, 2025 | -78.98% |
| Jun 30, 2025 | -151.29% |
| Mar 31, 2025 | -3.51% |
| Dec 31, 2024 | 32.11% |
| Sep 30, 2024 | 27.34% |
| Jun 30, 2024 | 57.14% |
| Mar 31, 2024 | 24.38% |
| Dec 31, 2023 | 31.83% |
| Sep 30, 2023 | 32.68% |
| Jun 30, 2023 | 35.14% |
| Mar 31, 2023 | 24.61% |
| Dec 31, 2022 | 18.19% |
| Sep 30, 2022 | 1.74% |
| Jun 30, 2022 | -71.48% |
| Mar 31, 2022 | -94.92% |
| Dec 31, 2021 | -18.62% |
| Sep 30, 2021 | -202.83% |